| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the National Cancer Institute of Canada Clinical Trials Group (Dr. Parulekar), Queen’s University, Kingston ON; the Department of Radiology (Drs. Di Primio, Matzinger, and Dennie), University of Ottawa, Ottawa ON; the Department of Internal Medicine, Section of Hematology/Oncology (Dr. Bociek), University of Nebraska Medical Centre, Omaha, NE.
Correspondence to: Wendy Parulekar, MD, National Cancer Institute of Canada Clinical Trials Group, Queens University, 82 Barrie St, Kingston, Ontario K7L 3N6, Canada; e-mail: wparulekar{at}ctg.queensu.ca
Abstract
Study objective: To evaluate the efficacy of small-bore (12 French vanSonnenberg) catheters compared with standard large-bore chest tubes in the drainage and sclerotherapy of malignant pleural effusions.
Design: Retrospective review.
Setting: An academic tertiary care hospital.
Patients: Adult patients with documented neoplasms and malignant pleural effusions, treated between 1986 and 1995.
Intervention: All patients included in the study underwent drainage of malignant pleural effusions either by large-bore chest tube or by ultrasound-guided small-bore catheter. After drainage, pleurodesis was performed.
Results: Outcome as defined by recurrence of effusion was determined by blinded examination of all postpleurodesis chest radiographs. We identified 58 cases of malignant pleural effusion in which small-bore catheters were used and 44 in which large-bore chest tubes were used. The majority of patients had breast (n = 56, 55%) or lung cancer (n = 29, 28%). The median age was 65 years. Fifty-nine patients were actively being treated with chemotherapy at the time of pleurodesis. The following sclerosing agents were used: talc, 27 (26%); tetracycline, 72 (70%); bleomycin, 2 (2%); and interferon, 1 (1%). Actuarial probabilities of recurrence at 6 weeks and 4 months were 45% and 53% for the small tubes vs 45% and 51% for the large tubes. Univariate and multivariate analyses failed to demonstrate that tube size had any influence on the rate of recurrence.
Conclusions: We were unable to detect any major differences in outcomes with the use of either size of chest tube. Our study suggests that small-bore catheters may be effective in the treatment of malignant pleural effusions and deserve further evaluation in prospectively designed trials.
Key Words: chest tubes • complications • indwelling catheters • malignant pleural effusion • pleurodesis • recurrence
This article has been cited by other articles:
|
|
 |
|
  A. R. Haas, D. H. Sterman, and A. I. Musani Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach Chest, September 1, 2007; 132(3): 1036 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aelony and W. Parulekar Dry Talc Pleurodesis Via Chest Tube Chest, January 1, 2003; 123(1): 308 - 308. [Full Text] [PDF]
|
|
|
|
|
|
G. Cardillo, F. Facciolo, L. Carbone, M. Regal, F. Corzani, A. Ricci, M. Di Martino, and M. Martelli Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 302 - 306. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
